Delayed Anoxic Encephalopathy after Carbon Monoxide Poisoning: Evaluation of Therapeutic Effect by Serial Diffusion-Tensor Magnetic Resonance Imaging and Neurocognitive Test

Ho‐Sung Ryu, Young-Wook Kim, Boo-Kyoung Jung, Yong Won KimJournal of the Korean Neurological Association 2018 · DOI

Abstract

Delayed anoxic encephalopathy (DAE) after carbon monoxide (CO) poisoning is characterized by neurological deterioration that occurs after recovery from acute CO intoxication. There has been no established therapy. We report a patient recovered from acute CO intoxication developed various neurological symptoms. After the administration of high dose prednisolone and anticholinesterase inhibitor, the therapeutic effect was remarkable and confirmed by quantitative analysis of diffusion-tensor imaging (DTI). DTI could be used to evaluate the therapeutic effect for delayed anoxic encephalopathy after CO poisoning.

Introduction

Carbon monoxide (CO) poisoning is a critical medical emergency, but its aftermath can include a "hidden" complication known as Delayed Anoxic Encephalopathy (DAE). Patients often appear to recover from the initial acute poisoning, entering a "lucid interval" of days or weeks, only to suffer a sudden, severe neurological relapse. This relapse is characterized by cognitive decline, movement disorders, and behavioral changes, likely stemming from delayed demyelination of the brain's white matter.

Currently, there is no universally accepted treatment guideline for DAE, and clinical recovery is often assessed subjectively. This case study explores the use of high-dose steroids and anticholinesterase inhibitors, utilizing serial Diffusion-Tensor Imaging (DTI) as an objective biomarker for recovery.

Methods and Case Presentation

The study focuses on a 79-year-old female patient who developed DAE 30 days after acute CO poisoning. Following the onset of symptoms—including apathy, urinary incontinence, and gait disturbance—she was treated with a combination of high-dose intravenous prednisolone (to suppress potential autoimmune-mediated demyelination) and an anticholinesterase inhibitor (to support cognitive function).

Clinical progress was tracked using the Korean Mini-Mental State Examination (K-MMSE) and comprehensive neurocognitive testing. To quantitatively measure structural brain recovery, the researchers employed DTI, focusing on Fractional Anisotropy (FA). FA measures the directionality of water diffusion; high values indicate healthy, organized white matter (myelin), while low values suggest structural breakdown. FA values were measured across 14 brain regions at baseline (DAE onset) and two months post-treatment.

Results

The patient showed remarkable clinical and structural improvement following the therapeutic intervention.

Cognitive and Functional Recovery

The patient’s cognitive performance improved significantly. Her K-MMSE score rose from a severely impaired 6/30 at baseline to 18/30 after two months. Neurocognitive testing revealed substantial gains in several domains, particularly language and memory, where percentiles jumped from near-zero to functional levels.

Neurocognitive test results showing significant percentile improvements in language and memory two months after treatment.

Neuroimaging and Structural Repair

Serial imaging provided visual and quantitative evidence of brain repair. While standard MRI sequences (DWI and FLAIR) showed the initial insult and subsequent white matter changes, the DTI-derived FA maps clearly illustrated the restoration of white matter integrity over time.

Serial MRI and DTI scans: (A) Acute stage, (B) Baseline DAE onset showing decreased white matter integrity, and (C) Two-month follow-up showing significant recovery in fractional anisotropy maps.

Quantitative analysis confirmed these visual findings. Significant increases in FA values were observed in the right high frontal lobe (+40.00%), left high frontal lobe (+28.00%), and the corpus callosum genu (+14.89%). These structural improvements correlated with the patient's return to her pre-illness lifestyle and the resolution of her physical symptoms.

Discussion

The success of this treatment protocol supports the hypothesis that DAE may involve an inflammatory or autoimmune-mediated demyelination process that can be mitigated by steroids. The use of DTI proved invaluable as it provided a quantitative "biomarker" that matched the patient's clinical trajectory.

Interestingly, the study noted regional differences in vulnerability; while white matter tracts showed repair, the basal ganglia exhibited a decrease in FA over time (roughly -22% to -30%), suggesting these areas are more susceptible to permanent hypoxic injury even when the patient shows overall clinical improvement.

Conclusion

This case demonstrates that a combination of high-dose steroids and anticholinesterase inhibitors can be effective in treating DAE. Furthermore, DTI is a sensitive tool for monitoring the therapeutic effect and quantifying white matter recovery. While limited by its single-patient scope, this study highlights the potential for DTI to guide clinical decision-making and the need for larger trials to standardize DAE treatment protocols.

Summary updated

Abstract

Delayed anoxic encephalopathy after carbon monoxide (CO) poisoning is characterized by neurological deterioration that occurs after recovery from acute CO intoxication. There has been no established therapy. We report a patient recovered from acute CO intoxication developed various neurological symptoms. After the administration of high dose prednisolone and anticholinesterase inhibitor, the therapeutic effect was remarkable and confirmed by quantitative analysis of diffusion-tensor imaging (DTI). DTI could be used to evaluate the therapeutic effect for delayed anoxic encephalopathy after CO poisoning.
BibTeX
@article{ryu2018delayed,
  author = {Ho‐Sung Ryu and Young-Wook Kim and Boo-Kyoung Jung and Yong Won Kim},
  title = {{Delayed Anoxic Encephalopathy after Carbon Monoxide Poisoning: Evaluation of Therapeutic Effect by Serial Diffusion-Tensor Magnetic Resonance Imaging and Neurocognitive Test}},
  journal = {Journal of the Korean Neurological Association},
  year = {2018},
  doi = {10.17340/jkna.2018.4.18},
}
Figure